VTRS

Viatris Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
$16.34
-0.55 (-3.26%)
Mkt Cap: 19.03B
Key Metrics
MetricValue
P/E RatioN/A
EV/EBITDAN/A
ROEN/A
Gross MarginN/A
Revenue GrowthN/A
FCF Yield13.3%
Dividend YieldN/A
Market Cap19.03B
Volume6.22M
Recent News
Cavendish reiterates 'buy' rating on Shield Therapeutics after US deal with Viatris
proactiveinvestors.co.uk · 2026-08-28
3 Generic Drug Stocks to Watch Amid Improving Industry Trends
zacks.com · 2026-08-27
Here's Why Viatris (VTRS) is a Strong Value Stock
zacks.com · 2026-08-18
Viatris Inc. (VTRS) Q2 2026 Earnings Call Transcript
seekingalpha.com · 2026-08-06
Viatris Inc (VTRS) Shares Fall 7.6% -- GF Value Says Still Overvalued
gurufocus.com · 2026-08-06
Viatris Sharpens Focus with Divestiture, Hikes 2026 Outlook
benzinga.com · 2026-08-06

Unlock the Full Deep Scan

9 AI agents analyze VTRS across earnings, insider flow, macro conditions, corporate strategy, market microstructure, and price action.

Sign Up Free →